drugset / Trial / NCT05050305
Marizomib Central Nervous System (CNS)
NaSingle-groupOpen-labelTreatment
Summary
This research is being done to test whether the investigational drug marizomib is safe and effective when used in combination with standard of care drugs for the treatment of multiple myeloma.
Timeline
- Start
- 2024-03
- Primary completion
- 2025-12
- Completion
- 2027-12
Outcome
Outcome not reported
Stopped: “Study support withdrawn”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Marizomib | Small molecule | — | Intravenous |
| Background | Dexamethasone | Small molecule | — | Oral |
| Background | Pomalidomide | Other / unclassified | — | Oral |